inPractice® - Injectable Contraceptives

Clinically important pharmacokinetic interactions between progestin injectable contraceptives and antiretrovirals have not been reported^{[Cohn 2007; Nanda 2008; Watts 2008; DHHS Perinatal]}
DMPA may be associated with an elevated HIV-1 RNA set point when used at the time of HIV acquisition^{[Lavreys 2004]}
Data suggesting an association between DMPA use and HIV acquisition or transmission are controversial, and additional studies are needed^{[Noguchi 2015; Polis 2013a; Polis 2013b; Polis 2013c; Lutalo 2013; Heffron 2012; Morrison 2012; McCoy 2013; Nanda 2017; ECHO 2019]}